Prediction of the benefits from dose-escalated hypofractionated intensity-modulated radiotherapy for prostate cancer

International Journal of Radiation Oncology Biology Physics

Volumn 56, Issue 1, 2003, Pages 199-207

  Amer, Ali M ^a   Mott, Judith ^a   Mackay, Ranald I ^a   Williams, Peter C ^a   Livsey, Jacqueline ^a   Logue, John P ^a   Hendry, Jolyon H ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Dose escalation; Patient movement; Prostate cancer; Radiobiologic modeling

Indexed keywords

PATIENT MONITORING; TISSUE; TUMORS;

INTENSITY-MODULATED RADIATION THERAPY (IMRT);

RADIOTHERAPY;

ARTICLE; CANCER CONTROL; CANCER RADIOTHERAPY; HUMAN; MATHEMATICAL MODEL; PATIENT POSITIONING; PREDICTION; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIATION DOSE FRACTIONATION; RECTUM DISEASE; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0037402518     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00086-5     Document Type: Article

References (24)

1. Brenner D.J., Hall E.J. Fractionation and protraction for radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys. 43:(5):1999;1095-1101.
2. Brenner D.J. Toward optimal external-beam fractionation for prostate cancer. Int J Radiat Oncol Biol Phys. 48:2000;315-316.
3. Fowler J., Chappell R., Ritter M. Is alpha/beta for prostate tumors really low. Int J Radiat Oncol Biol Phys. 50:(4):2001;1021-1031.
4. Joiner MC, van der Kogel AJ. The linear-quadratic approach to fractionation and calculation of isoeffect relationships. In: Steel GG, editor. Basic clinical radiobiology. London: Arnold;1997. p. 55-64.
5. Rew D.A., Wilson G.D. Cell production rates in human tissues and tumors and their significance. Part II: clinical data. Eur J Surg Oncol. 26:(4):2000;405-417.
6. Lloyd-Davies R.W., Collins C.D., Swan A.V. Carcinoma of prostate treated by radical external beam radiotherapy using hypofractionation. Twenty-two years' experience (1962-1984). Urology. 36:(2):1990;107-111.
7. Logue J.P., Cowan R.A., Hendry J.H. Hypofractionation for prostate cancer. Int J Radiat Oncol Biol Phys. 49:(5):2001;1522-1523.
8. Read G., Pointon R.C. Retrospective study of radiotherapy in early carcinoma of prostate. Br J Urol. 63:(2):1989;191-195.
9. Hanks G.E., Hanlon A.L., et al. Dose escalation with 3D conformal treatment Five year outcomes, treatment optimization, and future directions . Int J Radiat Oncol Biol Phys. 41:1998;501-510.
10. Pollack A., Zagars G., Lee J., et al. Preliminary results of a randomized radiotherapy dose escalation study comparing 70 Gy with 78 Gy for prostate cancer. J Clin Oncol. 18:(23):2000;3904-3911.
11. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 41:1998;491-500.
12. Michalski J., Purdy J., Winter K., et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys. 46:(2):2000;391-402.
13. Jackson A., Skwarchuk M.W., Zelefsky M.J., et al. Late rectal bleeding after conformal radiotherapy of prostate cancer (II) Volume effects and dose-volume histograms . Int J Radiat Oncol Biol Phys. 49:2001;685-698.
14. Storey M., Pollack A., Zagars G., et al. Complications from radiotherapy dose escalation in prostate cancer Preliminary results of a randomized trial . Int J Radiat Oncol Biol Phys. 48:(3):2000;635-642.
15. Webb S., Nahum A.E. A model for calculating tumor control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol. 38:1993;653-666.
16. Kallman P, Agren A, Brahme A. Tumor and normal tissue responses to fractionated non-uniform dose delivery. Int J Radiat Biol1992;62:249-262. Review.
17. MacKay R.I., Hendry J.H., Moore C.J., et al. Predicting late rectal complications following prostate conformal radiotherapy using biologically effective doses and normalized dose-surface histograms. Br J Radiol. 70:(833):1997;517-526.
18. Bel A., Vos P.H., Rodrigus P.T., et al. High-precision prostate cancer irradiation by clinical application of an offline patient setup verification procedure, using portal imaging. Int J Radiat Oncol Biol Phys. 35:1996;321-332.
19. van Herk M., Bruce A., Kroes A.P., et al. Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int J Radiat Oncol Biol Phys. 33:(5):1995;1311-1320.
20. Bey P., Carrie C., Beckendorf V., et al. Dose escalation with 3D-CRT in prostate cancer French study of dose escalation with conformal 3D radiotherapy in prostate cancer - Preliminary results . Int J Radiat Oncol Biol Phys. 48:2000;513-517.
21. Kupelian P.A., Reddy C.A., Klein E.A., et al. Short-course intensity-modulated radiotherapy (70 Gy at 2 5 Gy per fraction) for localized prostate cancer: Preliminary results on late toxicity and quality of life . Int J Radiat Oncol Biol Phys. 51:(4):2001;988-993.
22. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys1991;21:109-122. Review.
23. Bos L., Damen E., DE Boer R., et al. Reduction of rectal dose by integration of the boost in the large-field treatment plan for prostate irradiation. Int J Radiat Oncol Biol Phys. 52:(1):2002;254-265.
24. Amer A.M., Mackay R.I., Roberts S.A., et al. The required number of treatment imaging days for an effective off-line correction of systematic errors in conformal radiotherapy of prostate cancer - a radiobiologic analysis. Radiother Oncol. 61:2001;143-150.